Clinical Trial: Effect of Limosilactobacillus Reuteri on Social Deficits in Children With Autistic Spectrum Disorder

U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07845253) titled 'Effect of Limosilactobacillus Reuteri on Social Deficits in Children With Autistic Spectrum Disorder' on Sept. 22.

Brief Summary: This is a double-blind, randomized, placebo-controlled, parallel-group study in children with Autism Spectrum Disorder (ASD) to evaluate the effect of a probiotic product on the ASD symptoms.

Study Start Date: Oct. 15

Study Type: INTERVENTIONAL

Condition: Autism Spectrum Disorder

Intervention: DIETARY_SUPPLEMENT: Probiotics

Combination of L. reuteri strains.

DIETARY_SUPPLEMENT: Placebo

Placebo identical to the active product, except the addition of probiotics.

Recruitment Status: NOT_YET_RECRUI...